Trials / Not Yet Recruiting
Not Yet RecruitingNCT06495814
Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 380 (estimated)
- Sponsor
- Fengmei Lian · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Establish a comprehensive evaluation system for the progression of obese impaired glucose tolerance (IGT) to type 2 diabetes mellitus (T2DM) through cross-sectional studies; Constructing and validating a T2DM risk prediction model for obese IGT population through observational research; Through open-label clinical research, we applied Jinlida granules to intervene in high-risk obese IGT population and clarify its protective effect on this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1/bag of Jinlida granules, 3 times/day, taken with hot water. | All observation and intervention groups received lifestyle interventions, with only the intervention group of high-risk obese impaired glucose tolerance receiving intervention with Jinlida granules. |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2025-12-30
- Completion
- 2026-12-30
- First posted
- 2024-07-11
- Last updated
- 2024-07-11
Source: ClinicalTrials.gov record NCT06495814. Inclusion in this directory is not an endorsement.